Enhancing Lysosomal Function as a Therapeutic Strategy for Parkinson’s Disease

Time: 11:30 am
day: Track B - Day 2


  • Investigating lysosomal dysfunction in neurodegenerative diseases and what this means from a drug development perspective
  • Exploring activating TRPML1 as potential treatment for GBA-PD
  • Looking through the crystal ball: Outlining future Caraway directions